Physician profile
Jonathan Lim
NPI 1770163925
$1,748.77
in general payments reported to CMS, 2019-2025
9 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $167 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,000 · Food and Beverage: $666 · Consulting Fee: $82.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,000.00 |
| Food and Beverage | $666.18 |
| Consulting Fee | $82.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,079.01 | 2025 | |
| Grifols USA, LLC | $167.42 | 2024 | Xembify |
| Pharming Healthcare, INC. | $124.87 | 2025 | Ruconest |
| Biocryst US Sales Co., LLC | $89.81 | 2025 | Orladeyo |
| Adma Biomanufacturing LLC | $82.59 | 2025 | |
| Glaxosmithkline, LLC. | $62.27 | 2025 | Nucala |
| Amgen INC. | $60.27 | 2025 | Tezspire |
| Incyte Corporation | $58.25 | 2025 | Opzelura |
| Csl Behring | $24.28 | 2025 | Hizentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.